Implementation of Internet of Things Using Electrocardiogram Sensors to Identify Atrial Fibrillation Heart Disease

Muhammad Ramdan Pamungkas, Wawan Setiawan, Lala Septem Riza

Abstract


Atrial Fibrillation (AF) is one of the most common heart diseases and increases the risk of stroke and heart failure up to five times. The symptoms of AF are very diverse and often asymptomatic, so an immediate examination is needed to detect it. Given the dangers of AF that could lead to heart failure or death, a diagnosis that can record daily heart rhythms is urgently needed. Research trends show increased use of the Internet of Things (IoT) due to its efficiency and real-time monitoring capabilities. The purpose of this study is to utilize the IoT concept by designing a prototype AF detection device called Atrial Fibrillation Detector (AFD) using a ESP8266 microcontroller device and an AD8266 Electrocardiogram (ECG) sensor. The results of the study show that AFD can identify AF through 4 main stages, including the process of recording ECG data, the process of sending data from the AFD device to the server, the process of processing data to identify the appearance of AF and the process of sending notifications if there is an indication of the appearance of AF. To further test AFD, two experimental scenarios were applied; blackbox testing and comparison of the suitability of AF detection results. In the first experiment, AFD managed to pass the total number of scenarios that existed at 16 scenarios. In the second experiment, AFD only managed to identify exactly 9 out of 15 scenarios.

Keywords


Aritmia; Atrial fibrilasi; Elektrokardiogram; Internet of thinks

Full Text:

PDF

References


Andrade, J., Khairy, P., Dobrev, D., and Nattel, S. (2014). The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circulation research, 114(9), 1453-1468.

Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., ... and American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. (2019). Heart disease and stroke statistics—2019 update: a report from the American Heart Association. Circulation, 139(10), e56-e528.

Boriani, G., Diemberger, I., Martignani, C., Biffi, M., and Branzi, A. (2006). The epidemiological burden of atrial fibrillation: a challenge for clinicians and health care systems. European heart journal, 27(8), 893-894.

Chrisanto, E. Y., Novikasari, L., and Triyoso, T. (2019). Hubungan antara atrial fibrilasisimtomatik dan asimtomatik dengan klasifikasi gagal jantung menurut New York Heartassociation (NYHA) di ruang tulip RSUD dr. H. Abdul Moeloek propinsi Lampung. Malahayati Nursing Journal, 1(1).

Darby, A. E., and DiMarco, J. P. (2012). Management of atrial fibrillation in patients with structural heart disease. Circulation, 125(7), 945-957.

Faust, O., Shenfield, A., Kareem, M., San, T. R., Fujita, H., and Acharya, U. R. (2018). Automated detection of atrial fibrillation using long short-term memory network with RR interval signals. Computers in biology and medicine, 102, 327-335.

Go, A. S., Hylek, E. M., Phillips, K. A., Chang, Y., Henault, L. E., Selby, J. V., and Singer, D. E. (2001). Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. Jama, 285(18), 2370-2375.

Khoo, C. W., and Lip, G. Y. (2009). Acute management of atrial fibrillation. Chest, 135(3), 849-859.

Laitupa, A. A., and Amin, M. (2019). Ventilasi dan perfusi, serta hubungan antara ventilasi dan perfusi. Jurnal Respirasi, 2(1), 29-34.

Maharani, A., Sujarwoto, Praveen, D., Oceandy, D., Tampubolon, G., and Patel, A. (2019). Cardiovascular disease risk factor prevalence and estimated 10-year cardiovascular risk scores in Indonesia: The SMARThealth Extend study. PloS one, 14(4), e0215219.

Mesotten, L., Maes, A., Hambÿe, A. S., Everaert, H., Van den Maegdenbergh, V., Franken, P., and Mortelmans, L. (1998). Nuclear cardiology, Part I: anatomy and function of the normal heart. Journal of Nuclear Medicine Technology, 26(1), 4-8.

Miyasaka, Y., Barnes, M. E., Gersh, B. J., Cha, S. S., Bailey, K. R., Abhayaratna, W. P., ... and Tsang, T. S. (2006). Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation, 114(2), 119-125.

Ravi, V. P., and Singh, R. (2013). A study of cardiovascular diseases: Types and risk factor. JSIR Journal, 2(2), 433-459.

Sethi, N. J., Nielsen, E. E., Safi, S., Feinberg, J., Gluud, C., and Jakobsen, J. C. (2018). Digoxin for atrial fibrillation and atrial flutter: a systematic review with meta-analysis and trial sequential analysis of randomised clinical trials. PLoS One, 13(3), e0193924.

Streur, M. (2019). Atrial fibrillation symptom perception. The Journal for Nurse Practitioners, 15(1), 60-64.

Wolf, P. A., Abbott, R. D., and Kannel, W. B. (1991). Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. stroke, 22(8), 983-988.

Yuniadi, Y. (2017). Mengatasi aritmia, mencegah kematian mendadak. eJournal Kedokteran Indonesia, 5(3), 46-139.

Zareba, W., Moss, A. J., and le Cessie, S. (1994). Dispersion of ventricular repolarization and arrhythmic cardiac death in coronary artery disease. The American journal of cardiology, 74(6), 550-553.




DOI: https://doi.org/10.17509/jcs.v4i1.71177

Refbacks

  • There are currently no refbacks.